Table 2.

Targeted therapy of thyroid cancer.

Targeted therapy	Notes	Diseases	Drugs	References
Tyrosine kinase inhibitors	Inhibiting VEGFR, FGFR, PDGFR, and RET	PTC, FTC	Lenvatinib, Sorafenib	(100–103)
BRAF inhibitors	Inhibiting BRAF	PTC	Vemurafenib, Dabrafenib	(46, 104–106)
Immunotherapy	Inhibiting PD-L1	PTC, FTC	Atezolizumab, Durvalumab	(17, 107–109)
RET inhibitors	Inhibiting RET	PTC	Selpercatinib, Pralsetinib	(110–114)
MEK inhibitors	Inhibiting MEK	PTC, FTC	Trametinib, Cobimetinib	(115–117)